What happened with the FDA and compounded GLP-1s, and who is still operating legally?

Short answer

• The FDA has stepped in because many pharmacies were making unapproved “copies” of brand GLP‑1 drugs (semaglutide, tirzepatide, etc.) from bulk active ingredients. The agency says that practice can be illegal and unsafe if the compounders aren’t following the specific rules for compounding or are using non‑approved bulk drug substances. As a result the FDA has issued warning letters and public safety notices and asked some compounders to stop making these products.
• Legally available options now: (1) FDA‑approved GLP‑1 medicines from the drug makers (e.g., Novo Nordisk and Eli Lilly products), and (2) compounding pharmacies or outsourcing facilities that meet the law’s strict requirements (registered 503B outsourcing facilities or state‑licensed 503A pharmacies compounding for a valid individual prescription). Many compounding pharmacies stopped or limited GLP‑1 compounding after the FDA actions.

More detail (plain language) What triggered the FDA action

• High consumer demand for GLP‑1s created a market for cheaper, compounded versions made from bulk APIs (often sourced abroad).
• The FDA’s concerns: some compounders were making near‑identical copies of approved drugs (which generally isn’t allowed), using bulk drug substances that aren’t permitted for compounding, or lacking adequate quality controls. That raises risks from wrong potency, contamination, sterility failures, etc.
• The FDA responded with public guidance, warning letters, and enforcement actions against compounders that didn’t meet legal/quality requirements.

How compounding law works (short)

• 503A pharmacies (traditional compounding): may compound for an individual patient pursuant to a prescription, but they generally cannot make an “essentially a copy” of an FDA‑approved drug or use bulk drug substances unless allowed by law/state rules.
• 503B outsourcing facilities: register with FDA, follow current Good Manufacturing Practices (cGMP), can make larger batches, and are inspected by FDA — but they still must follow statutory limits (and the FDA scrutinizes use of bulk APIs and copies of approved drugs).
• State boards of pharmacy also regulate compounding pharmacies.

Who is still operating legally

• FDA‑approved manufacturers and their supply chain: use the brand products approved and made by the drug companies (safe/legal). Examples: Novo Nordisk (Ozempic, Wegovy, Rybelsus) and Eli Lilly (Mounjaro, Zepbound). These are manufactured under strict quality controls and FDA approval.
• Licensed prescribers (PCPs, endocrinologists) and pharmacies dispensing the brand products — legal and recommended.
• Some compounding pharmacies and 503B outsourcing facilities continue to operate legally by following the law: they only compound when there’s a valid individual prescription and medical need, or by complying with registration/cGMP rules. After FDA actions many labs stopped compounding GLP‑1s or tightened procedures.
• What you should avoid: buying compounded GLP‑1s from unknown online sellers, social‑media sellers, or pharmacies that cannot prove their legal status and quality testing.

If you’re considering a compounded product — what to ask and check

• Ask the pharmacy for:
  • Whether they’re a 503B outsourcing facility registered with FDA (ask for registration/inspection status) or a 503A pharmacy operating under a licensed pharmacist with a patient‑specific prescription.
  • Certificates of analysis (COA) for the active ingredient showing identity and purity.
  • Sterility and potency testing results for the finished batch.
  • State pharmacy license and any recent FDA warning letters or state board actions.
• If they can’t provide that documentation, don’t use the product.

Practical recommendation (safe choices)

• Prefer FDA‑approved products made by the manufacturers: Novo Nordisk (Ozempic, Wegovy, Rybelsus) and Eli Lilly (Mounjaro for diabetes; Zepbound for weight loss). These are regulated, labeled, and tested.
• For prescriptions and access, work with your primary care doctor or a reputable telehealth or specialty clinic that prescribes and dispenses through licensed pharmacies (examples of established telehealth providers: One Medical, PlushCare, or established weight‑management clinics). Make sure they fill prescriptions through legitimate pharmacies that supply brand products or, if they recommend a compound, can provide the documentation above.

If you want, I can

• Look up whether a specific compounding pharmacy (name) has an FDA warning letter or is registered as a 503B outsourcing facility.
• Explain how to check FDA warning letters and state board records yourself.